missing translation for 'onlineSavingsMsg'
Learn More

NOX2 Rabbit, anti-Human, Clone: 1B17, Proteintech

Rabbit Recombinant Monoclonal Antibody

149.00€ - 439.00€

Specifications

Antigen NOX2
Clone 1B17
Concentration 1000 μg/mL
Applications Western Blot, ELISA
Form Liquid
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18054465
View Documents
Proteintech
82872-1-RR-20UL
20 μL
149.00€
20µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
18086855
View Documents
Proteintech
82872-1-RR-100UL
100 μL
439.00€
100µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

The NOX2 antibody from Proteintech is a rabbit recombinant antibody generated with recombinant protein of human NOX2. This antibody recognizes human, mouse, rat antigen. The NOX2 antibody has been validated for the following applications: WB, ELISA analysis.

Specifications

Specifications

NOX2
1000 μg/mL
Liquid
Human, Mouse, Rat
CGD, CGD91 phox, CYBB, Cytochrome b 245 heavy chain, Cytochrome b(558) subunit beta, Cytochrome b558 subunit beta, GP91 1, GP91 PHOX, GP91PHOX, NADPH oxidase 2, NOX2, p22 phagocyte B cytochrome, p91 PHOX
Primary
1B17
Western Blot, ELISA
Rabbit
1536
IgG
Store at -20°C. Stable for one year after shipment.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.